Clincosm LogoSign in Get a demo

hepatitis d

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bulevirtide Therapy in Chronic Hepatitis Delta in Italy

Recruiting
  • Hepatitis D
  • Milan, MI, Italy
    Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
Nov 7, 2023

Bulevirtide Therapy in HDV Chronic Hepatitis in Italy

Completed
  • Hepatitis D
  • Milan, MI, Italy
    Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
Jul 24, 2023

DELTA DESCRIBE: THE FRENCH COLLABORATIVE PROJECT

Recruiting
  • Hepatitis D
  • Patients co-infected HBV/HDV
  • Limoges, France
    Chu Limoges
Jun 27, 2023

Hepatitis D Trial in Athens (Bulevirtide)

Recruiting
  • Hepatitis D
  • Athens, Greece
    Department of Gastroenterology, Medical School of National & Kap
Jun 28, 2023

Standardising Care for Hepatitis Delta in the Netherlands

Not yet recruiting
  • Hepatitis D
    • (no location specified)
    Jun 6, 2023

    Evaluation of Patients With Liver Disease

    Recruiting
    • Hepatitis D
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

      Terminated
      • Hepatitis B, Chronic
      • Hepatitis D
      • Chisinau, Republic Of Moldova, Moldova, Republic of
      • +1 more
      Nov 15, 2022

      Burden of Hepatitis D Virus Infection in China Through

      Not yet recruiting
      • Hepatitis D
      • +3 more
      • HDV-Ab (IgG), HDV-RNA, RNA genotype
      • (no location specified)
      Nov 1, 2022

      Hepatitis D Trial in Taipei (Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide)

      Not yet recruiting
      • Hepatitis D
      • Ursodeoxycholic acid
      • +2 more
      • Taipei, Taiwan
      • +1 more
      Jul 19, 2022

      Patients With Hepatitis D Virus (HDV) Infection in China

      Not yet recruiting
      • Hepatitis D
        • Beijing, Beijing, China
          Bejing Tsinghua Changgung Hospital
        Jul 7, 2022

        Disease Loads and Status of Treatment

        Recruiting
        • Chronic Hepatitis B
        • +2 more
        • Prospective serological assays
        • Retrospective serological assays
        • Taipei City, Taiwan
          National Taiwan University Hospital
        Feb 28, 2022

        Liver Disease, Hepatitis D Trial run by the NIDDK (Peg-interferon lambda, Lonafarnib, Ritonavir)

        Completed
        Has Results
        • Liver Disease
        • Hepatitis D
        • Peg-interferon lambda
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 6, 2021

        Improvement of Portal Hypertension During Viral Suppression in

        Recruiting
        • Hepatitis D
        • +3 more
        • Hannover, Lower Saxony, Germany
          Hannover Medical School
        Aug 25, 2021

        Hepatitis B, C and D and HIV Along Maroni River Bordering French

        Completed
        • Hepatitis B
        • +5 more
        • Questionnaire
        • +6 more
        • Cayenne, French Guiana
          General Hospital of Cayenne
        Aug 10, 2021

        Hepatitis D Trial in Worldwide

        Recruiting
        • Hepatitis D
          • Vienna, Austria
          • +17 more
          Feb 24, 2021

          Hepatitis B, Hepatitis D Trial in Worldwide (ARC-520, entecavir, pegylated interferon alpha 2a)

          Terminated
          Has Results
          • Hepatitis B
          • Hepatitis D
          • Camperdown, New South Wales, Australia
          • +32 more
          Jan 11, 2019

          Hepatitis D Trial run by the NIDDK (Lonafarnib, Ritonavir, Placebo)

          Completed
          Has Results
          • Hepatitis D
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Aug 27, 2018

          Epidemiology of Hepatitis B, C and Delta in Reunion Island

          Not yet recruiting
          • Hepatitis B
          • +2 more
            • (no location specified)
            Sep 4, 2018

            Hepatitis D Trial in Germany, Greece, Romania (PEG-IFN alfa-2a, Tenofovir, PEG-IFN alfa-2a, )

            Completed
            • Hepatitis D
            • PEG-IFN alfa-2a, Tenofovir
            • PEG-IFN alfa-2a, placebo
            • Berlin, Germany
            • +9 more
            Jan 26, 2018

            Mother-to-child Hepatitis D Transmission

            Completed
            • Hepatitis D
            • Transmission
              • Paris, France
                Hopital Lariboisiere
              Apr 26, 2017

              Hepatitis D Trial run by the NIDDK (Lonafarnib, Placebo)

              Completed
              Has Results
              • Hepatitis D
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Jul 18, 2016

              Hepatitis D Trial in San Francisco, Detroit (EBP921)

              Terminated
              • Hepatitis D
              • San Francisco, California
              • +1 more
              Aug 4, 2016

              Hepatitis D Trial run by the NIDDK (Peginterferon Alpha-2a)

              Completed
              Has Results
              • Hepatitis D
              • Peginterferon Alpha-2a
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Jul 9, 2013